Literature DB >> 7670957

Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma.

B F Asztalos1, P S Roheim.   

Abstract

The influence of dilution on apolipoprotein (apo) A-I-containing subpopulations was studied in human plasma. Agarose electrophoresis and two-dimensional agarose nondenaturing gradient polyacrylamide gel electrophoresis were used. Both in one- and two-dimensional electrophoresis, an increase of charge was observed that resulted in an increase of subpopulations with pre-alpha mobility. Dilution of plasma also resulted in a decrease in the size of apo A-I-containing pre-beta 1 subpopulations. The existence of smaller pre-beta 1 particles was confirmed by subjecting undiluted and 8x diluted plasma to 3% to 16% nondenaturing gradient gel electrophoresis for 4 hours. In addition to the generally observed pre-beta 1 subpopulations, smaller particles similar in size to the free apo A-I were detected even in the undiluted plasma. During dilution, the proportion of larger pre-beta 1 particles decreased while the smaller ones increased, and in 8x diluted plasma, almost all the pre-beta 1 was present in smaller sizes. Using 3% to 35% nondenaturing polyacrylamide gels run for 24 hours, no pre-beta 1 particles could be detected in 8x diluted plasma because the small pre-beta 1 electrophoresed out. These studies show that pre-beta 1 particles can be converted to smaller ones during dilution. It also was demonstrated that "free apo A-I-like" pre-beta 1 particles are present in undiluted plasma. The presence of these particles may have important physiological and pathophysiological functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670957     DOI: 10.1161/01.atv.15.9.1419

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  10 in total

Review 1.  New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism.

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2012-12-10       Impact factor: 5.922

2.  Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin.

Authors:  Ruijuan Du; Imelda Winarsih; Bow Ho; Jeak Ling Ding
Journal:  Am J Clin Exp Immunol       Date:  2012-05-30

3.  Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: relevance to high-density lipoprotein biogenesis.

Authors:  Shobini Jayaraman; Giorgio Cavigiolio; Olga Gursky
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

4.  Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?

Authors:  I C Gelissen; T Hochgrebe; M R Wilson; S B Easterbrook-Smith; W Jessup; R T Dean; A J Brown
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

5.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.

Authors:  Sheng-Ping Wang; Erin Daniels; Ying Chen; Jose Castro-Perez; Haihong Zhou; Karen O Akinsanya; Stephen F Previs; Thomas P Roddy; Douglas G Johns
Journal:  J Lipid Res       Date:  2013-07-29       Impact factor: 5.922

7.  Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I.

Authors:  Phu T Duong; Ginny L Weibel; Sissel Lund-Katz; George H Rothblat; Michael C Phillips
Journal:  J Lipid Res       Date:  2008-02-05       Impact factor: 5.922

8.  Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.

Authors:  Szilard Voros; Parag Joshi; Zhen Qian; Sarah Rinehart; Jesus G Vazquez-Figueroa; Hunt Anderson; Michael Elashoff; Laura Murrieta; Dimitri Karmpaliotis; Anna Kalynych; Charles Brown; Ernst Schaefer; Bela Asztalos
Journal:  J Am Heart Assoc       Date:  2013-11-19       Impact factor: 5.501

9.  Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.

Authors:  Svetlana A Didichenko; Alexei V Navdaev; Alexandre M O Cukier; Andreas Gille; Patrick Schuetz; Martin O Spycher; Patrice Thérond; M John Chapman; Anatol Kontush; Samuel D Wright
Journal:  Circ Res       Date:  2016-07-19       Impact factor: 17.367

Review 10.  High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  BBA Clin       Date:  2015-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.